Clinical Trial Update: The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial investigating nanoparticle-based methods to guide surgical treatment of prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Unspecified nanoparticle-guided surgical agent (prostate cancer)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING